Major histocompatibility class II (MHC-II) expression is critical for immune responses and is controlled by the MHC-II transactivator CIITA. CIITA is primarily regulated at the transcriptional level and is expressed from three main promoters with myeloid, lymphoid, and IFN-γ treated non-hematopoietic cells using promoters pI, pIII, and pIV, respectively. Recent studies in non-hematopoietic cells suggest a series of distal regulatory elements may be involved in regulating CIITA transcription. To identify distal elements in B cells, a DNase I-hypersensitivity screen was performed, revealing a series of potential novel regulatory elements. These elements were analyzed computationally and biochemically. Several regions displayed active histone ...
Major Histocompatibility Complex class II (MHCII) molecules direct the development, activation and h...
International audienceInnate and adaptive immunity are connected via antigen processing and presenta...
AbstractType II major histocompatibility complex combined immune deficiency (type II MHC CID or bare...
Major histocompatibility complex (MHC) class II molecules play a central role in immune responses, a...
By virtue of its control over major histocompatibility complex class II (MHC-II) gene expression, CI...
The class II trans-activator CIITA is a transcriptional co-activator required for the expression of ...
Precise regulation of MHC class II expression plays a crucial role in the control of the immune resp...
CIITA is a master transactivator of the major histocompatibility complex class II genes, which are i...
The Major Histocompatibility Complex (MHC) class II is an important family of molecules in the adapt...
The MHC class lI transactivator (CIITA) plays a central role in adaptive immune responses. CIITA dir...
Three distinct promoters control the master regulator of MHC class II expression, CIITA, in a cell t...
The class II transactivator (CIITA) is the master regulator of major histocompatibility complex clas...
In humans, T-cells accomplish expression of MHC-II molecules through induction of CIITA upon activat...
Great progress in understanding the relative importance of various portions of CIITA for transcripti...
AbstractCIITA, a gene that can complement a transcriptional mutation of the major histocompatibility...
Major Histocompatibility Complex class II (MHCII) molecules direct the development, activation and h...
International audienceInnate and adaptive immunity are connected via antigen processing and presenta...
AbstractType II major histocompatibility complex combined immune deficiency (type II MHC CID or bare...
Major histocompatibility complex (MHC) class II molecules play a central role in immune responses, a...
By virtue of its control over major histocompatibility complex class II (MHC-II) gene expression, CI...
The class II trans-activator CIITA is a transcriptional co-activator required for the expression of ...
Precise regulation of MHC class II expression plays a crucial role in the control of the immune resp...
CIITA is a master transactivator of the major histocompatibility complex class II genes, which are i...
The Major Histocompatibility Complex (MHC) class II is an important family of molecules in the adapt...
The MHC class lI transactivator (CIITA) plays a central role in adaptive immune responses. CIITA dir...
Three distinct promoters control the master regulator of MHC class II expression, CIITA, in a cell t...
The class II transactivator (CIITA) is the master regulator of major histocompatibility complex clas...
In humans, T-cells accomplish expression of MHC-II molecules through induction of CIITA upon activat...
Great progress in understanding the relative importance of various portions of CIITA for transcripti...
AbstractCIITA, a gene that can complement a transcriptional mutation of the major histocompatibility...
Major Histocompatibility Complex class II (MHCII) molecules direct the development, activation and h...
International audienceInnate and adaptive immunity are connected via antigen processing and presenta...
AbstractType II major histocompatibility complex combined immune deficiency (type II MHC CID or bare...